| COMPOSITION: | Empagliflozin 12.5 mg & Metformin 500 mg IR (Blister) |
| FORMULATION: | TABLET |
| STATUS: | PRESCRIPTION ONLY DRUG |
| DESCRIPTION: | Empaford is an anti-diabetic medication. It contains a combination of empagliflozin and metformin as active substances. It is used for the management of type 2 diabetes. |
| SIDE EFFECTS: | Nausea, vomiting, diarrhoea, abdominal pain, loss of appetite |
| DOSAGE/DIRECTIONS FOR USE: | As prescribed by the Physician. |
